Patent · US Active

Sulfonyl amide derivatives for the treatment of abnormal cell growth

US8247411B2 · kind B2 · utility

16Cited by

5References

17Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Michael Joseph Luzzio · Noank, US
Kevin Daniel Freeman-Cook · Clinton, US
Samit Kumar Bhattacharya · Groton, US
Matthew Merrill Hayward · Old Lyme, US
Catherine Angela Hulford · Preston, US
Christopher Lowell Autry · New London, US
Xumiao Zhao · East Lyme, US
Jun Xiao · New London, US
Kendra Louise Nelson · Mystic, US

Key dates

Filing date	Mar 11, 2011
Grant date	Aug 21, 2012
Priority date	—
Expiry date	Mar 11, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D475/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound of the formula Iwherein R1 to R6, A, B, n and m are as defined herein. Such novel sulfonyl amide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.